Effect of apoptosis and response of extracellular matrix proteins after chemotherapy application on human breast cancer cell spheroids

Oncology Reports

Volumn 15, Issue 2, 2006, Pages 335-340

  Oktem, Gülperi ^a   Vatansever, S ^b   Ayla, S ^c   Uysal, A ^a   Aktas, S ^d   Karabulut, B ^a   Bilir, A ^c  

^a EGE UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

^b CELAL BAYAR UNIVERSITY   (Turkey)

^c ISTANBUL UNIVERSITY   (Turkey)

^d Dr Behcet Uz Teaching Hospital for Children ^*  (Turkey)

Author keywords

Apoptosis; Chemotherapy; ECM proteins; Spheroid

Indexed keywords

ANTINEOPLASTIC AGENT; COLLAGEN TYPE 4; DOCETAXEL; DOXORUBICIN; KI 67 ANTIGEN; LAMININ; SCLEROPROTEIN; TAXOID;

APOPTOSIS; ARTICLE; CELL CULTURE; DRUG COMBINATION; DRUG EFFECT; FEMALE; GENE EXPRESSION; HUMAN; IMMUNOHISTOCHEMISTRY; METABOLISM; MULTICELLULAR SPHEROID; NICK END LABELING; PHYSIOLOGY; PROTO ONCOGENE; TUMOR SUPPRESSOR GENE;

ANTINEOPLASTIC AGENTS; APOPTOSIS; COLLAGEN TYPE IV; DOXORUBICIN; DRUG THERAPY, COMBINATION; EXTRACELLULAR MATRIX PROTEINS; FEMALE; GENE EXPRESSION; GENES, BCL-2; GENES, P53; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU NICK-END LABELING; KI-67 ANTIGEN; LAMININ; SPHEROIDS, CELLULAR; TAXOIDS; TUMOR CELLS, CULTURED;

EID: 33744479759     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.15.2.335     Document Type: Article

References (36)

1. Parkin DM, Laara E and Muir CS: Estimates of the world-wide frequency of sixteen major cancers in 1980. Int J Cancer 41: 184-197, 1988. (Pubitemid 18061141)
2. Quinn M and Allen E: Changes in incidence of and mortality from breast cancer in England and Wales since introduction of screening. United Kingdom Association of Cancer Registries. BMJ 311: 1391-1395, 1995.
3. Santini MT and Rainaldi G: Three-dimensional spheroid model in tumor biology (Review). Pathobiology 67: 148-157, 1999. (Pubitemid 29304376)
4. Becker JL, Prewett TL, Spaulding GF and Goodwin TJ: Threedimentional growth and differentiation of ovarian tumor cell line in high aspect rotating-wall vessel: Morphologic and embryologic considerations. J Cell Biochem 51: 283-289, 1993. (Pubitemid 23103604)
5. Streuli CH and Bissel MJ: Mammary epithelial cells, extracellular matrix, and gene expression. Cancer Treat Res 53: 365-381, 1991.
6. Boudreau N and Bissell MJ: Extracellular matrix signaling: integration of form and function in normal and malignant cells, Curr Opin Cell Biol 10: 640-646, 1998. (Pubitemid 28477023)
7. Colognato H and Yurchenco P: Form and function: the laminin family of heterotrimers. Dev Dyn 218: 213-234, 2000. (Pubitemid 30349637)
8. Terranova VP, Liotta LA, Russo RG and Martin GR: Role of laminin in the attachment and metastasis of murine tumor cells. Cancer Res 47: 2265-2269, 1982. (Pubitemid 12121444)
9. Chung AE, Jaffe R, Freeman I, Vergnes J, Braguiski J, Carlin B: Properties of a basement membrane-related glycoprotein synthesized in culture by a mouse embryonal carcinoma-derived cell line. Cell 16: 277-281, 1979.
10. Terranova VP, Rohrbach DH and Martin GR: Role of laminin in the attachment of PAM 212 (epithelial) cells to basement memebrane collagen. Cell 22: 719-728, 1980.
11. Cotran RS, Kumar V and Collins T: Robbins Pathological Basis of Disease. Saunders, Philadelphia, 1999.
12. Terranova VP, Rao CN, Kalebic T, Margulies IM and Liotta LA: Laminin receptor on human breast carcinoma cells. Cell Biol 80: 444-448, 1983. (Pubitemid 13174636)
13. Chintala SK, Gokaslan ZL, Go Y, Sawaya R, Nicolson GL and Rao JS: Role of extracellular matrix proteins in regulation of human glioma cell invasion in vitro . Clin Exp Metastasis 14: 358-366, 1996. (Pubitemid 26363210)
14. Fearon ER: Cancer progression. Curr Biol 9: R873-R875, 1999.
15. Hanahan D and Weinberg RA: The hallmarks of cancer. Cell 100: 57-70, 2000. (Pubitemid 30046295)
16. Casey RC, Burleson KM, Skubitz KM, Pambuccian SE, Oegema TR Jr, Ruff LE and Skubitz AP: Beta 1-integrins regulate the formation and adhesion of ovarian carcinoma multicellular spheroids. Am J Pathol 159: 2071-2080, 2001. (Pubitemid 33104261)
17. Kleinman HK, Klebe RJ and Martin GR: Role of collagenous matrices in the adhesion and growth of cells. J Cell Biol 88: 473-485, 1981. (Pubitemid 11097938)
18. Hay ED: Cell Biology of Extracellular Matrix. Hay ED (ed). Plenum, London, pp1-39, 1981.
19. Slee EA, O'Connor DJ and Lu X: To die or not to die: how does p53 decide? Oncogene 23: 2809-2818, 2004. (Pubitemid 38638844)
20. Mercurio AM, Bachelder RE, Chung J, O'Connor KL, Rabinovitz I, Shaw LM and Tani T: Integrin laminin receptors and breast carcinoma progression. J Mammary Gland Biol Neoplasia 6: 299-309, 2001.
21. Green DR: Apoptotic pathways: the roads to ruin. Cell 94: 695-698, 1998.
22. Kluck RM, Bossy-Wetzel E, Green DR and Newmeyer DD: The release of cytochrome c from mitochondria: a primary site for Bcl-2 regulation of apoptosis. Science 275: 1132-1136, 1997. (Pubitemid 27097313)
23. Kang HS, Youn YK, Oh SK, Choe KJ and Noh DY: Flow cytometric analysis of primary tumors and their corresponding metastatic nodes in breast cancer. Breast Cancer Res Treat 63: 81-87, 2000.
24. Frankel A, Man S, Elliott P, Adams J and Kerbel RS: Lack of multicellular drug resistance observed in human ovarian and prostate carcinoma treated with the proteasome inhibitor PS-341. Clin Cancer Res 6: 3719-3728, 2000.
25. Oktem G, Karabulut B, Selvi N, Sezgin C, Sanli UA, Uslu R, Yurtseven ME and Omay SB: Differential effects of doxorubicin and docetaxel on nitric oxide production and inducible nitric oxide synthase expression in MCF-7 human breast cancer cells. Oncol Res 14: 381-386, 2004. (Pubitemid 39070679)
26. Kroemer G: The proto-oncogene Bcl-2 and its role in regulating apoptosis. Nat Med 3: 614-620, 1997.
27. Krajewski S, Tanaka S, Takayama S, Schibler MJ, Fenton W and Reed JC: Investigation of the subcellular distribution of the bcl-2 oncoprotein: residence in the nuclear envelope, endoplasmic reticulum, and outer mitochondrial membranes. Cancer Res 53: 4701-4714, 1993. (Pubitemid 23304404)
28. Cherbonnel-Lasserre C, Gauny S and Kronenberg A: Suppression of apoptosis by Bcl-2 or Bcl-xL promotes susceptibility to mutagenesis. Oncogene 13: 1489-1497, 1996. (Pubitemid 26354197)
29. Laux MT, Aregullin M, Berry JP, Flanders JA and Rodriguez E: Identification of a p53-dependent pathway in the induction of apoptosis of human breast cancer cells by the natural product, resveratrol. J Altern Complement Med 10: 235-239, 2004. (Pubitemid 38525728)
30. Van Dierendonck JH, Keijzer R, van de Velde CJ and Cornelisse CJ: Nuclear distribution of the Ki-67 antigen during the cell cycle: comparison with growth fraction in human breast cancer cells. Cancer Res 49: 2999-3006, 1989. (Pubitemid 19148639)
31. Ronnov-Jessen L, Petersen OW and Bissell MJ: Cellular changes involved in conversion of normal to malignant breast: importance of the stromal reaction. Physiol Rev 76: 69-125, 1996. (Pubitemid 26048279)
32. Hagemann T, Robinson SC, Schulz M, Trumper L, Balkwill FR and Binder C: Enhanced invasiveness of breast cancer cell lines upon co-cultivation with macrophages is due to TNFalpha dependent up-regulation of matrix metalloproteases. Carcinogenesis 25: 1543-1549, 2004. (Pubitemid 39162720)
33. Coussens LM and Werb Z: Matrix metalloproteinases and the development of cancer. Chem Biol 3: 895-904, 1996. (Pubitemid 27017088)
34. Liotta LA and Stetler-Stevenson WG: Tumor invasion and metastasis: an imbalance of positive and negative regulation. Cancer Res 51: 5054-5059, 1991.
35. Gui GP, Puddefoot JR, Vinson GP, Wells CA and Carpenter R: In vitro regulation of human breast cancer cell adhesion and invasion via integrin receptors to the extracellular matrix. Br J Surg 82: 1192-1196, 1995.
36. Abecassis J, Millon-Collard R, Klein-Soyer C, Nicora F, Fricker JP, Beretz A, Eber M, Muller D and Cazenave JP: Adhesion of human breast cancer cell line MCF-7 to human vascular endothelial cells in culture. Enhancement by activated platelets. Int J Cancer 40: 525-531, 1987. (Pubitemid 17148741)